Can a gas save lungs? new trial tests nitric oxide for ARDS survival
NCT ID NCT07334873
First seen Jan 12, 2026 · Last updated May 20, 2026 · Updated 18 times
Summary
This study tests whether adding inhaled nitric oxide (iNO) to standard care can help adults with moderate-to-severe acute respiratory distress syndrome (ARDS) live longer. About 536 participants will be randomly assigned to receive iNO or a placebo through their ventilator. The main goal is to see if iNO reduces deaths within 28 days and increases time off the ventilator.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS (MODERATE OR SEVERE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.